Salarius Capital Expenditures from 2010 to 2024

SLRX Stock  USD 1.58  0.04  2.47%   
Salarius Pharmaceuticals Capital Expenditures yearly trend continues to be fairly stable with very little volatility. Capital Expenditures will likely drop to 2.85 in 2024. During the period from 2010 to 2024, Salarius Pharmaceuticals Capital Expenditures regression line of annual values had r-squared of  0.000081 and arithmetic mean of  251,626. View All Fundamentals
 
Capital Expenditures  
First Reported
2015-03-31
Previous Quarter
2
Current Value
2
Quarterly Volatility
333.3 K
 
Yuan Drop
 
Covid
Check Salarius Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Salarius Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 441.7 K, Depreciation And Amortization of 9.5 K or Interest Expense of 281.6 K, as well as many indicators such as Price To Sales Ratio of 97.37, Dividend Yield of 0.0011 or PTB Ratio of 3.05. Salarius financial statements analysis is a perfect complement when working with Salarius Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Salarius Pharmaceuticals Correlation against competitors.
For more information on how to buy Salarius Stock please use our How to Invest in Salarius Pharmaceuticals guide.

Latest Salarius Pharmaceuticals' Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of Salarius Pharmaceuticals over the last few years. Capital Expenditures are funds used by Salarius Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Salarius Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Salarius Pharmaceuticals' Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Salarius Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Very volatile
   Capital Expenditures   
       Timeline  

Salarius Capital Expenditures Regression Statistics

Arithmetic Mean251,626
Geometric Mean0.00
Coefficient Of Variation152.05
Mean Deviation218,677
Median265,617
Standard Deviation382,603
Sample Variance146.4B
Range1.5M
R-Value(0.01)
Mean Square Error157.6B
R-Squared0.000081
Significance0.97
Slope(769.28)
Total Sum of Squares2T

Salarius Capital Expenditures History

2024 2.85
2023 3.0
20221.5 M
2021null
2018 2600.0
2017113.5 K
2016559.4 K

About Salarius Pharmaceuticals Financial Statements

Salarius Pharmaceuticals investors use historical fundamental indicators, such as Salarius Pharmaceuticals' Capital Expenditures, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Salarius Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Expenditures 3.00  2.85 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Salarius Stock Analysis

When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.